"Itraconazole (IT) compared with amphotericin B (AMB) as empirical therapy for persistent fever of unknown origin (FUO) in neutropenic patients (PTS)" by Marc Boogaerts

Article

Itraconazole (IT) compared with amphotericin B (AMB) as empirical therapy for persistent fever of unknown origin (FUO) in neutropenic patients (PTS)

Bone Marrow Transplantation (1999)

Marc Boogaerts, Katholieke Universiteit Leuven
G Garber, University of Ottawa
D Winston, University of California, Los Angeles
A Reboli, University of Medicine and Dentistry of New Jersey
A Schwarer, Alfred Hospital
E Bow, University of Manitoba
M Peeters, Janssen Pharmaceutica
E Materman
K De Beule

Link

Disciplines

Medicine and Health Sciences

Publication Date

January 1, 1999

Citation Information

Marc Boogaerts, G Garber, D Winston, A Reboli, et al.. "Itraconazole (IT) compared with amphotericin B (AMB) as empirical therapy for persistent fever of unknown origin (FUO) in neutropenic patients (PTS)" Bone Marrow Transplantation Vol. 23 (1999)
Available at: http://works.bepress.com/annette-reboli/53/